499 related articles for article (PubMed ID: 15134988)
21. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
[TBL] [Abstract][Full Text] [Related]
22. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
Dinsmore WW; Wyllie MG
BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
[TBL] [Abstract][Full Text] [Related]
23. Role of testosterone in the treatment of hypoactive sexual desire disorder.
Schwenkhagen A; Studd J
Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
[TBL] [Abstract][Full Text] [Related]
24. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.
Diamond LE; Earle DC; Heiman JR; Rosen RC; Perelman MA; Harning R
J Sex Med; 2006 Jul; 3(4):628-638. PubMed ID: 16839319
[TBL] [Abstract][Full Text] [Related]
25. Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women.
Maserejian NN; Shifren J; Parish SJ; Segraves RT; Huang L; Rosen RC
J Sex Marital Ther; 2012; 38(1):41-62. PubMed ID: 22268981
[TBL] [Abstract][Full Text] [Related]
26. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
[TBL] [Abstract][Full Text] [Related]
27. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
28. Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder.
Clayton AH; Segraves RT; Leiblum S; Basson R; Pyke R; Cotton D; Lewis-D'Agostino D; Evans KR; Sills TL; Wunderlich GR
J Sex Marital Ther; 2006; 32(2):115-35. PubMed ID: 16418104
[TBL] [Abstract][Full Text] [Related]
29. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
[TBL] [Abstract][Full Text] [Related]
30. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
Pyke RE; Clayton AH
J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
[TBL] [Abstract][Full Text] [Related]
31. Testosterone therapy in women: a review.
Bolour S; Braunstein G
Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
[TBL] [Abstract][Full Text] [Related]
32. The function of sildenafil on female sexual pathways: a double-blind, cross-over, placebo-controlled study.
Caruso S; Intelisano G; Farina M; Di Mari L; Agnello C
Eur J Obstet Gynecol Reprod Biol; 2003 Oct; 110(2):201-6. PubMed ID: 12969584
[TBL] [Abstract][Full Text] [Related]
33. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial.
Clayton AH; Althof SE; Kingsberg S; DeRogatis LR; Kroll R; Goldstein I; Kaminetsky J; Spana C; Lucas J; Jordan R; Portman DJ
Womens Health (Lond); 2016 Jun; 12(3):325-37. PubMed ID: 27181790
[TBL] [Abstract][Full Text] [Related]
34. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
35. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study.
Caruso S; Rugolo S; Agnello C; Intelisano G; Di Mari L; Cianci A
Fertil Steril; 2006 May; 85(5):1496-501. PubMed ID: 16579999
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacological treatment of sexual dysfunction in women].
Hilmand CB; Gregersen N; Giraldi AG
Ugeskr Laeger; 2002 Oct; 164(41):4794-6. PubMed ID: 12407886
[No Abstract] [Full Text] [Related]
37. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women.
Rosen RC; Maserejian NN; Connor MK; Krychman ML; Brown CS; Goldstein I
Menopause; 2012 Apr; 19(4):396-405. PubMed ID: 22076307
[TBL] [Abstract][Full Text] [Related]
38. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.
Nathorst-Böös J; Flöter A; Jarkander-Rolff M; Carlström K; Schoultz Bv
Maturitas; 2006 Jan; 53(1):11-8. PubMed ID: 16183220
[TBL] [Abstract][Full Text] [Related]
39. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.
Goldstat R; Briganti E; Tran J; Wolfe R; Davis SR
Menopause; 2003; 10(5):390-8. PubMed ID: 14501599
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]